BioLife Solutions vs Lexeo Therapeutics
BioLife Solutions vs Lexeo Therapeutics, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioLife Solutions is on 54/100 and Lexeo Therapeutics on 61/100.
Where each one leads
BioLife Solutions
- domain rating: 49/100 against 41/100
- headcount: 193 against 91
Lexeo Therapeutics
- our overall score: 61/100 against 54/100
- agent readiness: 40/100 against 21/100
- funding raised: $495M against $96.4M
- LinkedIn following: 16,654 against 10,520
At a glance
| Measure | BioLife Solutions | Lexeo Therapeutics |
|---|---|---|
| What it is | Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, MedTech, HealthTech, Cell and Gene Therapy | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | platform | Platform |
| Founded | 1987 | 2020 |
| Headquarters | Bothell, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioLife Solutions | Lexeo Therapeutics |
|---|---|---|
| Employees | 193 | 91 |
| Headcount growthLast 12 months | +21.0% | Not published |
| Total funding | $96.4M | $495M |
| Latest round | Private Placement | Public Offering |
| LinkedIn followers | 10,520 | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioLife Solutions | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 61/100 |
| Traction | 60/100 | 60/100 |
| Team | 50/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 30/100 | 28/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 49/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioLife Solutions | Lexeo Therapeutics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
BioLife Solutions vs Lexeo Therapeutics: common questions
Which is better, BioLife Solutions or Lexeo Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do BioLife Solutions and Lexeo Therapeutics compare on the numbers?
BioLife Solutions leads on domain rating (49/100 against 41/100), headcount (193 against 91). Lexeo Therapeutics leads on our overall score (61/100 against 54/100), agent readiness (40/100 against 21/100), funding raised ($495M against $96.4M), LinkedIn following (16,654 against 10,520).
Read the full BioLife Solutions review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other BioLife Solutions alternatives we track.